Binge Eating Disorder
📧 Sign up to get email alerts when something new happens for Binge Eating Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-03-18FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for lisdexamfetamine dimesylate (generic). This action approves changes to…
-
FDA approval · 2025-09-23FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America, expanding the approve…
-
FDA approval · 2025-06-16FDA Approved: ARYNTA — Original Application (Azurity Pharmaceuticals, Inc.)
FDA approved ARYNTA (lisdexamfetamine dimesylate oral) from Azurity Pharmaceuticals under an Original Application NDA. This entry documents …
-
FDA approval · 2025-01-29FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals' lisdexamfetamine dimesylate as a generic drug (Original Application) with indications for attention-d…
-
FDA approval · 2025-01-23FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for lisdexamfetamine dimesylate from Camber Pharmaceuticals, enabling its generic product to be …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-12-17FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (SpecGx LLC)
FDA approved lisdexamfetamine dimesylate as a generic version of Vyvanse under an Original Application (ANDA) from SpecGx LLC. The product i…
-
FDA approval · 2024-12-16FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals Inc.'s original application for lisdexamfetamine dimesylate, a generic version of the ADHD medication,…
-
FDA approval · 2024-11-15FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Elite Laboratories, Inc.)
FDA approved the original application for lisdexamfetamine dimesylate as a generic product from Elite Laboratories, Inc., confirming regulat…
-
FDA approval · 2024-10-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for lisdexamfetamine dimesylate (ANDA 217068), allowing marketing of a generic…
-
FDA approval · 2024-09-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application for lisdexamfetamine dimesylate (generic) submitted by SpecGx LLC under ANDA 211840.
-
FDA approval · 2024-09-16FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's supplemental application to market lisdexamfetamine dimesylate as a generic drug, expanding access…
-
FDA approval · 2024-09-16FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
The FDA approved a supplemental application for lisdexamfetamine dimesylate from Teva Pharmaceuticals under an ANDA, approving changes to th…
-
FDA approval · 2024-07-26FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Sandoz Inc)
The FDA approved Sandoz Inc's original generic application for lisdexamfetamine dimesylate, authorizing its use as a stimulant medication. T…
-
FDA approval · 2024-06-04FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Solco Healthcare US,LLC)
FDA approved a supplemental application for lisdexamfetamine dimesylate capsules submitted by Solco Healthcare US, LLC. The approval covers …
-
FDA approval · 2024-02-14FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for lisdexamfetamine dimesylate (generic) from Lannett Company, Inc., enabling a new generic pro…
-
FDA approval · 2024-02-02FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved an original ANDA for lisdexamfetamine dimesylate (Novadoz Pharmaceuticals LLC), a generic version of the stimulant used to trea…
-
FDA approval · 2024-01-30FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for lisdexamfetamine dimesylate by Apotex Corp., approving a generic product under the supplemental …
-
FDA approval · 2024-01-05FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's supplemental application for lisdexamfetamine dimesylate, a generic version of the ADHD medication.
-
FDA approval · 2023-10-13FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, indicating an…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' lisdexamfetamine dimesylate as an original-application generic product under ANDA 217068.
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves lisdexamfetamine dimesylate (generic) from Mylan as an Original Application; the generic is approved for the same indications a…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (SpecGx LLC)
FDA approved lisdexamfetamine dimesylate under an Original Application (generic) filed by SpecGx LLC.
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Alvogen Inc.)
FDA approved the original ANDA for lisdexamfetamine dimesylate (generic) from Alvogen, enabling a generic version of the ADHD and binge eati…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Teva Pharmaceuticals, Inc.)
The FDA approved Teva's original ANDA for lisdexamfetamine dimesylate, establishing a generic version of the prodrug used to treat ADHD and …
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Rhodes Pharmaceuticals)
FDA approved an original generic application for lisdexamfetamine dimesylate from Rhodes Pharmaceuticals for the treatment of ADHD and binge…